AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 587 businesses audited.
Medical Devices, Pharma & Biotech BS: NEUPRO (UCB, Inc.) (neupro.com)
A high-substance, low-bullshit pharmaceutical site that prioritizes regulatory compliance and technical specificity over marketing hyperbole. It avoids the ‘breakthrough’ clichés common in the industry by focusing on its unique physical delivery form (the patch) and documented clinical trial deltas.
Implement Organization and Product schema with sameAs links to UCB’s corporate profile and the FDA approval registry to bridge the technical authority gap. Add direct citations (PMID or DOI numbers) to the body text where ‘clinical trials’ are mentioned to provide a direct proof path for efficacy claims. Include a ‘Scientific Publications’ section that lists peer-reviewed studies supporting the 24-hour continuous delivery claim. Ensure Restless Legs Syndrome content is as dense as the Parkinson’s data to maintain cross-indication consistency.
The information density is high, with specific technical data points provided across all pages. Substance is found in the mention of four distinct dosing strengths (2mg, 4mg, 6mg, 8mg) and specific clinical trial outcomes, such as patients experiencing 2 hours less ‘off’ time and 2.5 hours more ‘on’ time. Unlike generic medical sites, it avoids fluff-heavy H1 headings, opting for descriptive markers like FOR PARKINSON’S DISEASE or Indication. The body text is dominated by mandatory safety information, which is the opposite of marketing fluff.
AI crawlers don't scroll, click, or wait — they take whatever the raw HTML gives them. Start your free crawl layer inspection and see whether your site is actually reachable in an AI native environment.
The site demonstrates near-zero semantic drift. The homepage H1 WELCOME TO NEUPRO and the primary signal of being a ‘transdermal system’ are consistently supported on every sub-page. The sub-pages deliver exactly what the hero section promises: detailed information on why a patch is effective (stable, continuous delivery 24 hours a day) and how it compares to traditional treatments like Levodopa. There are no contradictions between the ‘once-daily partner’ positioning on the homepage and the technical descriptions in the deeper pages.
Identify the current state and friction diagnosis of your specific business model. Generate your Executive SEO Strategy to quantify the financial or conversion cost of strategic misalignment.
Trust theatre is minimal because the site does not use unverified reviews (review_count is 0), which would be a regulatory violation. However, there is a minor evidence gap as efficacy claims like ‘NEUPRO has proven efficacy’ and ‘In clinical trials… patients saw improvement’ are not directly hyperlinked to specific peer-reviewed study citations or ClinicalTrials.gov identifiers in the text provided. The site relies on its FDA approval status as the primary proof path, which is high-authority but lacks the granularity of direct research links.
The ratio of verifiable evidence to assertions is favorable. Across the four pages, the site provides specific counts (1 million Americans with PD), specific dosing, and specific trial metrics. The absence of external proof links in the metadata is offset by the highly granular technical specifications of the drug’s delivery and the specific mention of FDA approval for specific indications.
To see how the system reconstructs a medical entity graph at scale, review the full Cleveland Clinic Structured Data audit. View the Cleveland Clinic Structured Data Audit for a live example of identity level decomposition and cross page entity mapping.
The value proposition is highly unique for its category, explicitly claiming to be the ‘first and only Parkinson’s patch.’ This prevents the content from being a commodity copy-paste for competitors who primarily offer oral medications. The use of industry jargon like ‘dopamine agonist’ and ‘transdermal system’ is justified by the technical nature of the product. Boilerplate sections like ‘Important Safety Information’ and ‘Indication’ are industry standard requirements rather than generic marketing templates.
Authority is established through the sponsorship of UCB, Inc., though the technical implementation lacks structured data (schema_json is null). While it mentions ‘healthcare professionals,’ it does not name a specific medical advisory board or provide Person schema for lead researchers, which is a common but notable gap in digital authority. The authority is corporate (brand-led) rather than expert-led (individual doctor credentials).
The performance claims are remarkably grounded in measurable clinical data. The site avoids vague ‘best-in-class’ assertions, instead defining success through ‘motor function and activities of daily living’ and specific hours of ‘on’ versus ‘off’ time. There is no disconnect between the marketing promise of ’24-hour’ delivery and the technical explanation of the transdermal delivery mechanism.
Medical Devices, Pharma & Biotech BS: NEUPRO (UCB, Inc.) (neupro.com)
The site perfectly aligns with the Medical Pharma & Biotech category. It focuses exclusively on rotigotine transdermal system delivery for Parkinson’s and RLS, adhering to strict regulatory content requirements for prescription medication.
AI retrieval begins with one question: "What is this page?" Read the Structured Data Technical Guide to learn how correct entity typing and persistent identifiers prevent your site from collapsing into noise.
“The score of 26 is driven primarily by the Trust and Proof pillar (10/20) due to the lack of direct external links to published clinical papers, and the Identity pillar (5/15) due to missing structured data. The Information Density and Semantic Coherence pillars scored very low for BS (high substance), reflecting the site's factual and consistent nature.”